J Alan Diehl

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Endoplasmic Reticulum

Top Venues

Molecular cancer research : MCR

Nature cell biology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Neekkan Dey, Constantinos Koumenis, Davide Ruggero, Serge Y Fuchs, J Alan Diehl
miR-217 Regulates Normal and Tumor Cell Fate Following Induction of Endoplasmic Reticulum Stress. Molecular cancer research : MCR 22 (4) (2024)
Neekkan Dey, Constantinos Koumenis, Davide Ruggero, Serge Y Fuchs, J Alan Diehl
miR-217 Regulates Normal and Tumor Cell Fate Following Induction of Endoplasmic Reticulum Stress. Molecular cancer research : MCR 22 (4) (2024)
Neekkan Dey, Constantinos Koumenis, Davide Ruggero, Serge Y Fuchs, J Alan Diehl
miR-217 regulates normal and tumor cell fate following induction of Endoplasmic Reticulum Stress. Molecular cancer research : MCR (2024)
Neekkan Dey, Constantinos Koumenis, Davide Ruggero, Serge Y Fuchs, J Alan Diehl
miR-217 Regulates Normal and Tumor Cell Fate Following Induction of Endoplasmic Reticulum Stress. Molecular cancer research : MCR 22 (4) (2024)
Neekkan Dey, Constantinos Koumenis, Davide Ruggero, Serge Y Fuchs, J Alan Diehl
miR-217 regulates normal and tumor cell fate following induction of Endoplasmic Reticulum Stress. Molecular cancer research : MCR (2024)
Zhen Lu, Ioannis I Verginadis, Motofumi Kumazoe, Gerardo M Castillo, Yao Yao, Rebecca E Guerra, Sandra Bicher, Menghao You, George McClung, Rong Qiu, Zebin Xiao, Zhen Miao, Subin S George, Daniel P Beiting, Takashi Nojiri, Yasutake Tanaka, Yoshinori Fujimura, Hiroaki Onda, Yui Hatakeyama, Akiko Nishimoto-Ashfield, Katrina Bykova, Wei Guo, Yi Fan, Nikolay M Buynov, J Alan Diehl, Ben Z Stanger, Hirofumi Tachibana, Terence P F Gade, Ellen Puré, Constantinos Koumenis, Elijah M Bolotin, Serge Y Fuchs
Modified C-type natriuretic peptide normalizes tumor vasculature, reinvigorates antitumor immunity, and improves solid tumor therapies. Science translational medicine 16 (761) (2024)
Karen J Dunbar, Tatiana A Karakasheva, Qiaosi Tang, Gizem Efe, Eric W Lin, Michael Harris, Varun Sahu, Uma M Sachdeva, Jianhua Hu, Andres J Klein-Szanto, Brian S Henick, J Alan Diehl, Hiroshi Nakagawa, Anil K Rustgi
Tumor-derived CCL5 recruits cancer-associated fibroblasts and promotes tumor cell proliferation in esophageal squamous cell carcinoma. Molecular cancer research : MCR (2023)
Sagar Bajpai, Hong Ri Jin, Bartosz Mucha, J Alan Diehl
Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCF Fbxl8 . Cancer biology & therapy 23 (1) (2022)
Akihiro Yoshida, Polly Phillips-Mason, Vincenzo Tarallo, Stefanie Avril, Christopher Koivisto, Gustavo Leone, J Alan Diehl
Non-phosphorylatable cyclin D1 mutant potentiates endometrial hyperplasia and drives carcinoma with Pten loss. Oncogene 41 (15) (2022)
Bartosz Mucha, Shuo Qie, Sagar Bajpai, Vincenzo Tarallo, J Nathaniel Diehl, Frank Tedeschi, Gao Zhou, Zhaofeng Gao, Samuel P Flashner, Andres J Klein-Szanto, Hanina Hibshoosh, Shimonosono Masataka, Olga S Chajewski, Ireneusz Majsterek, Dariusz Pytel, Maria Hatzoglou, Channing J Der, Hiroshi Nakagawa, Adam J Bass, Kwok-Kin Wong, Serge Y Fuchs, Anil K Rustgi, Eckhard Jankowsky, J Alan Diehl
Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation. Nature communications 13 (1) (2022)
Hongru Zhang, Pengfei Yu, Vivek S Tomar, Xiangjie Chen, Matthew J Atherton, Zhen Lu, Hong-Guang Zhang, Shifeng Li, Angelica Ortiz, Jun Gui, N Adrian Leu, Fangxue Yan, Andres Blanco, Mirella L Meyer-Ficca, Ralph G Meyer, Daniel P Beiting, Jinyang Li, Selene Nunez-Cruz, Roddy S O'Connor, Lexus R Johnson, Andy J Minn, Subin S George, Constantinos Koumenis, J Alan Diehl, Michael C Milone, Hui Zheng, Serge Y Fuchs
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors. Nature cancer 3 (7) (2022)
Ioannis I Verginadis, Harris Avgousti, James Monslow, Giorgos Skoufos, Frank Chinga, Kyle Kim, Nektaria Maria Leli, Ilias V Karagounis, Brett I Bell, Anastasia Velalopoulou, Carlo Salas Salinas, Victoria S Wu, Yang Li, Jiangbin Ye, David A Scott, Andrei L Osterman, Arjun Sengupta, Aalim Weljie, Menggui Huang, Duo Zhang, Yi Fan, Enrico Radaelli, John W Tobias, Florian Rambow, Panagiotis Karras, Jean-Christophe Marine, Xiaowei Xu, Artemis G Hatzigeorgiou, Sandra W Ryeom, J Alan Diehl, Serge Y Fuchs, Ellen Puré, Constantinos Koumenis
A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression. Nature cell biology 24 (6) (2022)
Andrea C Chaikovsky, Chuan Li, Edwin E Jeng, Samuel Loebell, Myung Chang Lee, Christopher W Murray, Ran Cheng, Janos Demeter, Danielle L Swaney, Si-Han Chen, Billy W Newton, Jeffrey R Johnson, Alexandros P Drainas, Yan Ting Shue, José A Seoane, Preethi Srinivasan, Andy He, Akihiro Yoshida, Susan Q Hipkins, Edel McCrea, Carson D Poltorack, Nevan J Krogan, J Alan Diehl, Christina Kong, Peter K Jackson, Christina Curtis, Dmitri A Petrov, Michael C Bassik, Monte M Winslow, Julien Sage
The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D. Nature 592 (7856) (2021)
Akihiro Yoshida, Jaewoo Choi, Hong Ri Jin, Yan Li, Sagar Bajpai, Shuo Qie, J Alan Diehl
Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3. Oncogene 40 (2) (2020)
Feven Tameire, Ioannis I Verginadis, Nektaria Maria Leli, Christine Polte, Crystal S Conn, Rani Ojha, Carlo Salas Salinas, Frank Chinga, Alexandra M Monroy, Weixuan Fu, Zhiping Wang, Andrew Kossenkov, Jiangbin Ye, Ravi K Amaravadi, Zoya Ignatova, Serge Y Fuchs, J Alan Diehl, Davide Ruggero, Constantinos Koumenis
ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression. Nature cell biology 21 (7) (2019)
Shuo Qie, Akihiro Yoshida, Stuart R Parnham, Natalia Oleinik, Gyda C Beeson, Craig C Beeson, Besim Ogretmen, Adam J Bass, Kwok-Kin Wong, Anil K Rustgi, J Alan Diehl
Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma. Nature communications 10 (1) (2019)
Katelyn M Williams, Shuo Qie, James H Atkison, Sabrina Salazar-Arango, J Alan Diehl, Shaun K Olsen
Structural insights into E1 recognition and the ubiquitin-conjugating activity of the E2 enzyme Cdc34. Nature communications 10 (1) (2019)
Akihiro Yoshida, Yiwen Bu, Shuo Qie, John Wrangle, E Ramsay Camp, Edward S Hazard, Gary Hardiman, Renée de Leeuw, Beatrice Knudsen, J Alan Diehl
SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors. Science advances 5 (9) (2019)
Gabrielle S Wong, Jin Zhou, Jie Bin Liu, Zhong Wu, Xinsen Xu, Tianxia Li, David Xu, Steven E Schumacher, Jens Puschhof, James McFarland, Charles Zou, Austin Dulak, Les Henderson, Peng Xu, Emily O'Day, Rachel Rendak, Wei-Li Liao, Fabiola Cecchi, Todd Hembrough, Sarit Schwartz, Christopher Szeto, Anil K Rustgi, Kwok-Kin Wong, J Alan Diehl, Karin Jensen, Francesco Graziano, Annamaria Ruzzo, Shaunt Fereshetian, Philipp Mertins, Steven A Carr, Rameen Beroukhim, Kenichi Nakamura, Eiji Oki, Masayuki Watanabe, Hideo Baba, Yu Imamura, Daniel Catenacci, Adam J Bass
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nature medicine 24 (7) (2018)
Yiwen Bu, Akihiro Yoshida, Nilesh Chitnis, Brian J Altman, Feven Tameire, Amanda Oran, Victoria Gennaro, Kent E Armeson, Steven B McMahon, Gerald B Wertheim, Chi V Dang, Davide Ruggero, Constantinos Koumenis, Serge Y Fuchs, J Alan Diehl
A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival. Nature cell biology 20 (1) (2017)
Alexander McQuiston, J Alan Diehl
Recent insights into PERK-dependent signaling from the stressed endoplasmic reticulum. F1000Research 6 (2017)